Dr. Pauly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2220 North Druid Hills Rd
South Tower Cl15224
Atlanta, GA 30329Phone+1 404-785-3730Fax+1 404-785-3600
Education & Training
- Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
- University of Alabama Medical CenterResidency, Pediatrics, 2005 - 2008
- Medical College of Georgia at Augusta UniversityClass of 2005
Certifications & Licensure
- GA State Medical License 2010 - 2025
- AL State Medical License 2007 - 2009
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
- Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia Start of enrollment: 2015 Dec 01
Publications & Presentations
PubMed
- Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed-rearranged acute lymphoblastic leukemia: Children's Oncol...Erin M Guest, John A Kairalla, Meenakshi Devidas, Emily Hibbitts, Andrew J Carroll
Haematologica. 2024-12-01 - Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemi...Anupam Verma, Yueh-Yun Chi, Jemily Malvar, Adam Lamble, Sonali Chaudhury
Cancers. 2024-01-24 - 10 citationsSingle-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia.Hope Mumme, Beena E Thomas, Swati S Bhasin, Upaasana Krishnan, Bhakti Dwivedi
Nature Communications. 2023-10-05
Abstracts/Posters
- Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)Melinda Pauly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Children’s Healthcare of Atlanta Opens First Clinical Trial for New Therapy Targeting LeukemiaApril 12th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: